Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy;Ocena zależności miȩdzy indeksem masy ciała a leptyna̧ u dzieci z rozpoznaniem ostrej białaczki limfoblastycznej w trakcie leczenia podtrzymuja̧cego remisjȩ i po jego zakończeniu

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 12, Issue 2, 2006, Pages 91-95

  Muszyńska Rosłan, Katarzyna ^a   Krawczuk Rybak, Maryna ^a   Topczewska, Magda ^b   Sawicka Zukowska, Małgorzata ^a  

^a AM   (Poland)

^b Zakład Informatyki Politechniki Białostockiej ^*

Author keywords

Acute lymphoblastic leukemia; Body mass index; Children; Leptin

Indexed keywords

ANTINEOPLASTIC AGENT; LEPTIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PUBERTY; SKULL IRRADIATION; ACUTE LYMPHOCYTIC LEUKEMIA; ADIPOSE TISSUE; ADULT; BLOOD; BODY COMPOSITION; CHILD; DRUG EFFECT; FOLLOW UP; METABOLISM; POLAND; PRESCHOOL CHILD; RADIATION EXPOSURE; REFERENCE VALUE; SEX DIFFERENCE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BODY COMPOSITION; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; POLAND; PUBERTY; REFERENCE VALUES; SEX FACTORS;

EID: 33745927430     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Arslanian S., Suprasongsin C., Kalhan S.C. i wsp.: Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity and energy expenditure. Metabolism, 1998, 47, 309-312.
2. Ahmed S.F., Wallace W.H.B., Kelnar C.J.H.: An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm. Res., 1997, 48, 178-183.
3. Birkebaek N.H., Fisker S., Clausen N. i wsp.: Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med. Pediatr. Oncol., 1998, 30, 351-356.
4. Meacham L.R., Gurney J.G., Meriens A.C. i wsp.: Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study. Cancer, 2005, 103, 1730-1739.
5. Rogers P., Meacham L., Oeffinger K. i wsp.: Obesity in pediatric oncology. Ped. Blood Cancer, 2005, 45, 881-891.
6. Palczewska I., Szilagyi-Pagowska I.: Ocena rozwoju somatycznego dzieci i mlodzieży. Med. Prakt., 2002, 3, 1-30.
7. Blum W.F., Englaro P., Hanitsch S. i wsp.: Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J. Clin. Endocrinol. Metab, 1997, 82, 2904-2910.
8. Juul A., Dalgaard P., Blum W.F. i wsp.: Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab, 1995, 80, 2534-2542.
9. Jarfelt M., Lannering B, Bosaeus I. i wsp.: Body composition in young adult survivors of childhood acute lymphoblastic leukemia. Eur. J. Endocrinol., 2005, 153, 81-90.
10. Kourti M., Tragiannidis A., Makedou A. i wsp.: Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J. Pediatr. Hematol. Oncol., 2005, 27, 499-501.
11. Oeffinger K.C., Mertens A.C., Sklar C. i wsp.: Obesity in adult survivors of childhood leukemia: a report from the childhood cancer survivors study. J. Clin. Oncol, 2003, 21, 1359-1365.
12. Shaw M.P., London D.C.H., Bath L.E. i wsp.: Obesity in leukemia survivors. Pediatr. Hem. Oncol., 2000, 17, 231-237.
13. Dalton V.K., Rue M., Silverman L.B. i wsp.: Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J. Clin. Oncol., 2003, 21, 2953-2960.
14. Krawczuk-Rybak M., Muszynska-Rostan K., Kitszel A. i wsp.: Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Rocz. Akad. Med. Bialymst., 2005, 50, 208-211.
15. Krawczuk-Rybak M., Kaliszewski J., Kitszel A.: The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after acute lymphoblastic leukemia therapy completed. Endokrynol. Diabetol. Chor. Przemiany Materii Wieku Rozw., 2003, 9, 41-47.
16. Arguelles B., Barrios V., Buňo M. i wsp.: Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study. Eur. J. Endocrinol., 2000, 143, 243-250.
17. Davies J.H., Evans B.A., Jones E. i wsp.: Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin. Endocrinol., 2004, 60, 358-365.
18. Krawczuk-Rybak M., Muszyńska-Rostan K., Konstantynowicz J. i wsp.: Relationship of leptin values to fat body mass (FM) and lean body mass (LBM) after antineoplastic treatment. Med. Wieku Rozwoj., 2004, 8, 297-307.
19. Baillargenon J., Langevin A.M., Lewis M. i wsp.: Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia. Cancer, 2005, 103, 1725-1729.
20. Wallace A.M., Tucker P., Wiliams D.M. i wsp.: Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin. Endocrinol., 2003, 58, 770-776.